Nelson Vergel
Founder, ExcelMale.com
Thanks to the revelation that Dodger baseball star Manny Ramirez used—and is now suspended for the use of—human chorionic gonadotropin (HCG), this compound is now known to the general public. It is now common knowledge that HCG can enhance athletic performance.
HCG is also a new, emerging treatment that appears to have great potential as an adjunct to opioid pain treatment. Adverse publicity involving anabolic steroids has already caused most of them to be removed from the commercial market and thus depriving physicians and patients of beneficial treatment options. Unfortunately, the Ramirez fiasco has the potential to tarnish the image of HCG and cause it to be restricted for medical uses.
Due to the HCG sports controversy and despite very early clinical experience, we want to let practitioners know that HCG is starting to be used as an adjunct in severe, chronic pain patients. Use in pain patients is a far cry from its use to enhance athletic performance. To alert practitioners to HCG’s potential, some of my preliminary clinical experiences with HCG are reported here. To date it appears quite beneficial, safe and easy to administer. Some females with low testosterone serum levels have greatly benefited from its use.
Over a year ago, Practical Pain Management published articles about the emerging use of hormonal treatments, including HCG, in pain practice. Hormone therapy in pain patients is now being used for replacement—particularly of testosterone and cortisol. HCG stimulates the production of testosterone, progesterone, estradiol, and thyroid—all of which should bring obvious benefits to some pain patients. HCG may also achieve pain reduction through neurogenesis and tissue healing.
Why Has HCG Entered Pain Practice?
.
HCG is also a new, emerging treatment that appears to have great potential as an adjunct to opioid pain treatment. Adverse publicity involving anabolic steroids has already caused most of them to be removed from the commercial market and thus depriving physicians and patients of beneficial treatment options. Unfortunately, the Ramirez fiasco has the potential to tarnish the image of HCG and cause it to be restricted for medical uses.
Due to the HCG sports controversy and despite very early clinical experience, we want to let practitioners know that HCG is starting to be used as an adjunct in severe, chronic pain patients. Use in pain patients is a far cry from its use to enhance athletic performance. To alert practitioners to HCG’s potential, some of my preliminary clinical experiences with HCG are reported here. To date it appears quite beneficial, safe and easy to administer. Some females with low testosterone serum levels have greatly benefited from its use.
Over a year ago, Practical Pain Management published articles about the emerging use of hormonal treatments, including HCG, in pain practice. Hormone therapy in pain patients is now being used for replacement—particularly of testosterone and cortisol. HCG stimulates the production of testosterone, progesterone, estradiol, and thyroid—all of which should bring obvious benefits to some pain patients. HCG may also achieve pain reduction through neurogenesis and tissue healing.
Why Has HCG Entered Pain Practice?
Human Chorionic Gonadotropin in Pain Treatment
Thanks to the revelation that Dodger baseball star Manny Ramirez used—and is now suspended for the use of—human chorionic gonadotropin (HCG), this compound is now known to the general public. It is now common knowledge that HCG can enhance athletic performance.
www.practicalpainmanagement.com